Sacred Plants and Mental Health in Latin America

Autor/innen

  • M.Sc. Oscar Espin European Institute for Multidisciplinary Studies on Human Rights and Science - Knowmad Institut
  • Rev. Martin Díaz European Institute for Multidisciplinary Studies on Human Rights and Science - Knowmad Institut https://orcid.org/0000-0001-5162-4786

DOI:

https://doi.org/10.5281/zenodo.7235793

Abstract

Sacred plants have a number of phenomena that revolve around their ritual and medicinal use, as well as being seen as carrying a bond with the sphere of the sacred. México is the country that has the greatest diversity of sacred plants in the Americas because its indigenous groups have a magical-religious relationship with them. In the beginning of the study of sacred plants, psilocybin, mescaline and ergotamine began to be classified as classical psychedelics, this categorization was of great help to psychiatry and neuroscience in the 1950s and 1960s.

Autor/innen-Biografie

M.Sc. Oscar Espin, European Institute for Multidisciplinary Studies on Human Rights and Science - Knowmad Institut

Master of Science im Fachbereich Public Mental Health der Nationalen Autonomen Universität von Mexiko (2020), Sozialanthropologe der Nationalen Schule für Anthropologie und Geschichte (2012).

Gegenwärtig entwickelt er qualitative Forschung im Bereich der psychischen Gesundheit; er arbeitet direkt mit Menschen, die psychoaktive Substanzen konsumieren, sowohl in kontrollierten klinischen Settings, Gruppen und Selbsthilfevereinen, als auch in Freizeitkontexten, in denen Substanzkonsum stattfindet

Literaturhinweise

➔ Anderson T, Petrankerz R, Rosenbaum D, Weissman C, Williams A, Huis, K, Hapkes E, (2018). Microdosing psychedelics:personality, mental health and creativity, differences in microdosers. Journal of Psychopharmacology.

➔ Barone W. Beck j & Mitsunaga-Whitten. (2019). Perceived benefits of MDMA – Assiste psychotherapy beyond symptom reduction: qualittaive follow -uo study of a clinical trial for individual with treatment- resistan PTSD. Journal of Psychoactive Drugs. 2019 March 8. Doi:10.1080/02791072.2019.1580805

➔ Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., et al. (2016). Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. The Lancet Psychiatry, 3(7), 619-627. doi:10.1016/S2215-0366(16)30065-7

➔ De Gregorio, Enns, Nuñez, Posa & Gobbi. (2018). D-Lysergic acid diethylamide, psilocybin and other classic hallucinogens: Mechanism of action and potential therapeutic applications in modo disorders. Progress in Brain Research. Elsevier

➔ Eliade Mircea (1998). Sagrado y profano. Barcelona, Paidos.

➔ European Monitoring Centre for Drugs and Drug Addiction. (2016). European Drug Report 2016: Trends and Developments. Publications Office of the European Union, Luxembourgp

➔ Johnson, MW, Hendricks,PS, Barret FS, Griffiths,RR. (2018). Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics Journal, December 4, 2018.

➔ Samorini,G. (2001). Los alucinógenos en el mito. La Liebre de Marzo. Barcelona

➔ Schultes R.E & Hofmann A. (1983). Plantas de los dioses: Orígenes del uso de los alucinogenos. Fonde de Cultura Económica. México ➔ Organización Mundial de la Salud. (2004). Invertir en salud mental. Ginebra. Suiza.

➔ United Nations (2015) Transforming our world: The 2030 agenda of sustainable development. Geneve. Switzerland

➔ World Health Organization (2013). Investing in mental health: Evidence for action. Geneve,Switzerland.

Sacred Plants

Veröffentlicht

2019-05-22

Zitationsvorschlag

Espin García, O. H., & Díaz Velásquez, M. I. (2019). Sacred Plants and Mental Health in Latin America. Journal für multidisziplinäre Studien Zu Menschenrechten Und Wissenschaften, 1(1-4). https://doi.org/10.5281/zenodo.7235793

URN